Analyst Reco. Pfizer, Inc.

Equities

Market Closed - Nyse Other stock markets 04:01:36 2024-04-26 pm EDT			5-day change	1st Jan Change
25.4 ^USD	+0.55%		-2.31%	-11.77%

Apr. 26	S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings	MT
Apr. 26	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT

Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer	Apr. 17	MT
Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board	Apr. 15	MT
PFIZER INC : JP Morgan remains Neutral	Apr. 12	ZD
Skanska Trims Scope of Work for Biomanufacturing Facility Project in US	Apr. 12	MT
PFIZER INC : Berenberg remains Neutral	Apr. 10	ZD
Argus Downgrades Pfizer to Hold From Buy	Mar. 22	MT
PFIZER INC : JP Morgan sticks Neutral	Mar. 07	ZD
PFIZER INC : JP Morgan sticks Neutral	Mar. 01	ZD
Guggenheim Initiates Pfizer With Buy Rating, Price Target is $36	Feb. 23	MT
China move leaves markets unfazed	Feb. 20
Indian shares set to open higher ahead of national budget	Jan. 31	RE
UBS Trims Pfizer Price Target to $28 From $29, Maintains Neutral Rating	Jan. 31	MT
PFIZER INC : UBS gives a Neutral rating	Jan. 31	ZD
PFIZER INC : Buy rating from Jefferies	Jan. 30	ZD
PFIZER INC : DZ Bank maintains a Buy rating	Jan. 30	ZD
PFIZER INC : JP Morgan gives a Neutral rating	Jan. 30	ZD
PFIZER INC : UBS reaffirms its Neutral rating	Jan. 30	ZD
PFIZER INC : JP Morgan remains Neutral	Jan. 30	ZD
PFIZER INC : Berenberg gives a Neutral rating	Jan. 25	ZD
PFIZER INC : Gets a Neutral rating from JP Morgan	Jan. 22	ZD

No results for this search

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs